Exome-Asset-Management

Filing Details

13F-HR/A2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-16
Total Holdings
59
Total Value
112495086
Accession Number
0001420506-25-001316
Form Type
13F-HR/A
Manager Name
Exome-Asset-Management
Data Enrichment
80% identified
47 identified12 unidentified

Holdings

59 positions • $112.5M total value
Manager:
Search and click to pin securities to the top
Page 2 of 3
Penumbra Inc
Shares:9.0K
Value:$2.4M
% of Portfolio:2.1% ($2.4M/$112.5M)
Savara Inc
Shares:836.4K
Value:$2.3M
% of Portfolio:2.1% ($2.3M/$112.5M)
ANAPTYSBIO, INC
Shares:116.6K
Value:$2.2M
% of Portfolio:1.9% ($2.2M/$112.5M)
Travere Therapeutics, Inc.
Shares:118.0K
Value:$2.1M
% of Portfolio:1.9% ($2.1M/$112.5M)
Centessa Pharmaceuticals plc
Shares:142.7K
Value:$2.1M
% of Portfolio:1.8% ($2.1M/$112.5M)
GE HealthCare Technologies Inc.
Shares:25.4K
Value:$2.1M
% of Portfolio:1.8% ($2.1M/$112.5M)
Fulcrum Therapeutics, Inc.
Shares:689.1K
Value:$2.0M
% of Portfolio:1.8% ($2.0M/$112.5M)
Structure Therapeutics Inc.
Shares:102.9K
Value:$1.8M
% of Portfolio:1.6% ($1.8M/$112.5M)
Immunome Inc.
Shares:263.8K
Value:$1.8M
% of Portfolio:1.6% ($1.8M/$112.5M)
07725L102
Shares:6.5K
Value:$1.8M
% of Portfolio:1.6% ($1.8M/$112.5M)
Crinetics Pharmaceuticals, Inc.
Shares:51.3K
Value:$1.7M
% of Portfolio:1.5% ($1.7M/$112.5M)
Edgewise Therapeutics, Inc.
Shares:71.4K
Value:$1.6M
% of Portfolio:1.4% ($1.6M/$112.5M)
DR REDDYS LABORATORIES LTD
Shares:117.5K
Value:$1.5M
% of Portfolio:1.4% ($1.5M/$112.5M)
Corbus Pharmaceuticals Holdings, Inc.
Shares:289.7K
Value:$1.5M
% of Portfolio:1.4% ($1.5M/$112.5M)
48576UAA4
Shares:2.0M
Value:$1.5M
% of Portfolio:1.4% ($1.5M/$112.5M)
NEKTAR THERAPEUTICS
Shares:2.2M
Value:$1.5M
% of Portfolio:1.3% ($1.5M/$112.5M)
ARVINAS, INC.
Shares:195.3K
Value:$1.4M
% of Portfolio:1.2% ($1.4M/$112.5M)
Gossamer Bio, Inc.
Shares:1.1M
Value:$1.2M
% of Portfolio:1.1% ($1.2M/$112.5M)
Trevi Therapeutics, Inc.
Shares:163.7K
Value:$1.0M
% of Portfolio:0.9% ($1.0M/$112.5M)
MBX Biosciences, Inc.
Shares:133.1K
Value:$982.4K
% of Portfolio:0.9% ($982.4K/$112.5M)